H.R. 7265 · 117th Congress · House

Cerebral Palsy Research Program Authorization Act of 2022

Active· Referred to the Subcommittee on Health.
Introduced
Mar 29, 22
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Cerebral Palsy Research Program Authorization Act of 2022

This bill expands research activities related to cerebral palsy (a group of disorders caused by abnormal brain development or damage that affects an individual's ability to move and maintain balance and posture).

Specifically, the Centers for Disease Control and Prevention must carry out a cerebral palsy research program that addresses diagnosis and treatment, public health surveillance, and related matters.

Additionally, the National Institute of Neurological Disorders and Stroke and the Eunice Kennedy Shriver National Institute of Child Health and Human Development must update an existing strategic plan for cerebral palsy research.

Action Timeline

5
  1. MAR 30, 2022Committee

    Referred to the Subcommittee on Health.

  2. MAR 29, 2022IntroReferral

    Introduced in House

  3. MAR 29, 2022IntroReferral

    Introduced in House

  4. MAR 29, 2022IntroReferral

    Sponsor introductory remarks on measure. (CR E311)

  5. MAR 29, 2022IntroReferral

    Referred to the House Committee on Energy and Commerce.

Committees

2

Health Subcommittee

hsif14

Referred: Mar 30, 2022

Active

Energy and Commerce Committee

hsif00

Referred: Mar 29, 2022

Active